Winston A - Search Results

1

Cognitive impairment in people living with HIV: consensus recommendations for a new approach.

Nightingale S, Ances B, Cinque P, Dravid A, Dreyer AJ, Gisslén M, Joska JA, Kwasa J, Meyer AC, Mpongo N, Nakasujja N, Pebody R, Pozniak A, Price RW, Sandford C, Saylor D, Thomas KGF, Underwood J, Vera JH, Winston A. Nightingale S, et al. Among authors: winston a. Nat Rev Neurol. 2023 Jul;19(7):424-433. doi: 10.1038/s41582-023-00813-2. Epub 2023 Jun 13. Nat Rev Neurol. 2023. PMID: 37311873 Review.

2

The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients.

Winston A, Mandalia S, Pillay D, Gazzard B, Pozniak A. Winston A, et al. AIDS. 2002 Oct 18;16(15):2087-9. doi: 10.1097/00002030-200210180-00018. AIDS. 2002. PMID: 12370512

3

Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase.

Winston A, Pozniak A, Mandalia S, Gazzard B, Pillay D, Nelson M. Winston A, et al. AIDS. 2004 Apr 9;18(6):949-51. doi: 10.1097/00002030-200404090-00014. AIDS. 2004. PMID: 15060444 No abstract available.

4

Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopy.

Vera JH, Garvey LJ, Allsop JM, Kaye S, McClure MO, Back D, Taylor-Robinson SD, Winston A. Vera JH, et al. Among authors: winston a. HIV Clin Trials. 2012 Jul-Aug;13(4):222-7. doi: 10.1310/hct1304-222. HIV Clin Trials. 2012. PMID: 22849963

5

The safety of flucloxacillin in HIV-infected patients with positive HLA-B*5701 genotype.

Vera JH, Naous N, Mackie N, Winston A, Cooke G. Vera JH, et al. Among authors: winston a. AIDS. 2013 Jan 28;27(3):484-5. doi: 10.1097/QAD.0b013e32835a9a0d. AIDS. 2013. PMID: 23032409

6

Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects.

Mora-Peris B, Croucher A, Else LJ, Vera JH, Khoo S, Scullard G, Back D, Winston A. Mora-Peris B, et al. Among authors: winston a. J Antimicrob Chemother. 2013 Jun;68(6):1348-53. doi: 10.1093/jac/dkt006. Epub 2013 Jan 30. J Antimicrob Chemother. 2013. PMID: 23364475

7

HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient subgroups.

Pozniak A, Rackstraw S, Deayton J, Barber T, Taylor S, Manji H, Melvin D, Croston M, Nightingale S, Kulasegaram R, Pitkanen M, Winston A. Pozniak A, et al. Among authors: winston a. Antivir Ther. 2014;19(1):1-13. doi: 10.3851/IMP2563. Epub 2013 Mar 21. Antivir Ther. 2014. PMID: 23519006 Review.

8

Can antiretroviral therapy prevent HIV-associated cognitive disorders?

Winston A, Vera JH. Winston A, et al. Curr Opin HIV AIDS. 2014 Jan;9(1):11-6. doi: 10.1097/COH.0000000000000016. Curr Opin HIV AIDS. 2014. PMID: 24275675 Review.

9

Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy.

Mora-Peris B, Watson V, Vera JH, Weston R, Waldman AD, Kaye S, Khoo S, Mackie NE, Back D, Winston A. Mora-Peris B, et al. Among authors: winston a. J Antimicrob Chemother. 2014 Jun;69(6):1642-7. doi: 10.1093/jac/dku018. Epub 2014 Feb 11. J Antimicrob Chemother. 2014. PMID: 24521854

10

Controversies in HIV-associated neurocognitive disorders.

Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T. Nightingale S, et al. Among authors: winston a. Lancet Neurol. 2014 Nov;13(11):1139-1151. doi: 10.1016/S1474-4422(14)70137-1. Lancet Neurol. 2014. PMID: 25316020 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

493 results

Search Page

Filters